ChemoCentryx, Inc. - Product Pipeline Review - 2016

  • ID: 3960457
  • Company Profile
  • 56 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Jyant Technologies, Inc
  • Polyphor Ltd.
  • MORE
ChemoCentryx, Inc. - Product Pipeline Review - 2016

The report ‘ChemoCentryx, Inc. - Product Pipeline Review - 2016’, provides an overview of the ChemoCentryx, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by ChemoCentryx, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of ChemoCentryx, Inc.
- The report provides overview of ChemoCentryx, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses ChemoCentryx, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features ChemoCentryx, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate ChemoCentryx, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for ChemoCentryx, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding ChemoCentryx, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Jyant Technologies, Inc
  • Polyphor Ltd.
  • MORE
Introduction

ChemoCentryx, Inc. Snapshot

ChemoCentryx, Inc. Overview

Key Facts

ChemoCentryx, Inc. - Research and Development Overview

Key Therapeutic Areas

ChemoCentryx, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

ChemoCentryx, Inc. - Pipeline Products Glance

ChemoCentryx, Inc. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

ChemoCentryx, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

ChemoCentryx, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

ChemoCentryx, Inc. - Drug Profiles

CCR-23G - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCR-93G - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-140 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-168 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-354 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-507 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-6239 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-650 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-771 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-872 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-9588 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CCX-991 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize CCR1 for Undisclosed Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize CXCR6 for Autoimmune, Oncology and Liver Diseases - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Target C5aR for Undisclosed Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize CCR and CXCR for Oncology and Autoimmune Disease - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

vercirnon sodium - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ChemoCentryx, Inc. - Pipeline Analysis

ChemoCentryx, Inc. - Pipeline Products by Target

ChemoCentryx, Inc. - Pipeline Products by Route of Administration

ChemoCentryx, Inc. - Pipeline Products by Molecule Type

ChemoCentryx, Inc. - Pipeline Products by Mechanism of Action

ChemoCentryx, Inc. - Dormant Projects

ChemoCentryx, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

CCX-832

vercirnon sodium

ChemoCentryx, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

ChemoCentryx, Inc., Key Facts

ChemoCentryx, Inc. - Pipeline by Indication, 2016

ChemoCentryx, Inc. - Pipeline by Stage of Development, 2016

ChemoCentryx, Inc. - Monotherapy Products in Pipeline, 2016

ChemoCentryx, Inc. - Phase III, 2016

ChemoCentryx, Inc. - Phase II, 2016

ChemoCentryx, Inc. - Phase I, 2016

ChemoCentryx, Inc. - Preclinical, 2016

ChemoCentryx, Inc. - Discovery, 2016

ChemoCentryx, Inc. - Pipeline by Target, 2016

ChemoCentryx, Inc. - Pipeline by Route of Administration, 2016

ChemoCentryx, Inc. - Pipeline by Molecule Type, 2016

ChemoCentryx, Inc. - Pipeline Products by Mechanism of Action, 2016

ChemoCentryx, Inc. - Dormant Developmental Projects,2016

ChemoCentryx, Inc. - Discontinued Pipeline Products, 2016

ChemoCentryx, Inc., Subsidiaries

List of Figures

ChemoCentryx, Inc. - Pipeline by Top 10 Indication, 2016

ChemoCentryx, Inc. - Pipeline by Stage of Development, 2016

ChemoCentryx, Inc. - Monotherapy Products in Pipeline, 2016

ChemoCentryx, Inc. - Pipeline by Top 10 Target, 2016

ChemoCentryx, Inc. - Pipeline by Route of Administration, 2016

ChemoCentryx, Inc. - Pipeline by Molecule Type, 2016

ChemoCentryx, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- ChemoCentryx, Inc.
- Jyant Technologies, Inc
- Polyphor Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll